Brief: Kyverna Therapeutics And Elevatebio Enter Into Commercial Manufacturing And Supply Agreement For Miv-Cel
27/07/2026 13:10
BRIEF-Kyverna Therapeutics And Elevatebio Enter Into Commercial Manufacturing And Supply Agreement For Miv-Cel July 27 (Reuters) - Kyverna Therapeutics Inc KYTX.O:
KYVERNA THERAPEUTICS AND ELEVATEBIO ENTER INTO COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT FOR MIV-CEL
KYVERNA THERAPEUTICS - AGREEMENT PROVIDES SCALABLE MIV-CEL SUPPLY FOR POTENTIAL SPS AND GMG LAUNCHES
KYVERNA THERAPEUTICS - ON TRACK TO COMPLETE ROLLING BLA SUBMISSION FOR MIV-CEL IN SPS IN Q4 2026
Source text: ID:nGNX1r5dFh
Further company coverage: KYTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyverna Therapeutics
See all newsHealth Rounds: Appendix removal linked with lower colon cancer risk in study
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden Restaurants